Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Patent
1997-09-29
1999-11-09
Brouillette, D. Gabrielle
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
424449, A61F 1302
Patent
active
059809337
ABSTRACT:
The present invention provides a method for treating Alzheimer's Disease using a xanomeline transdermal formulation. The invention provides desired transdermal xanomeline patch formulations.
REFERENCES:
patent: 4316893 (1982-02-01), Rajadhyaksha
patent: 4908027 (1990-03-01), Enscore et al.
patent: 5043345 (1991-08-01), Sauerberg et al.
patent: 5089267 (1992-02-01), Hille et al.
patent: 5130319 (1992-07-01), Pinza et al.
patent: 5238933 (1993-08-01), Catz et al.
patent: 5260314 (1993-11-01), Sauerberg et al.
patent: 5344656 (1994-09-01), Enscore et al.
Bymaster Franklin Porter
Horstmann Michael
Shannon Harlan E.
Shipley Lisa A.
Valia Kirti H.
Brouillette D. Gabrielle
Eli Liily and Company
Palmberg Arleen
LandOfFree
Transdermal formulation of xanomeline does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal formulation of xanomeline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal formulation of xanomeline will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1452122